NS · Healthcare

Zenith Drugs Ltd (ZENITHDRUG)

Pharmaceuticals & Biotechnology

Zenith Drugs Ltd (ZENITHDRUG) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $728.80M, P/E ratio is 18.57, dividend yield is 1.18%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ZENITHDRUG

Market cap

$728.80M

P/E ratio

18.57

Dividend yield

1.18%

Zenith Drugs Ltd (ZENITHDRUG) — FAQ

What is Zenith Drugs Ltd's market cap?

Zenith Drugs Ltd (ZENITHDRUG) has a reported market cap of $728.80M (data as of 2026-07-10).

What is ZENITHDRUG's P/E ratio?

The price-to-earnings (P/E) ratio for Zenith Drugs Ltd (ZENITHDRUG) is 18.57 (data as of 2026-07-10).

Does Zenith Drugs Ltd pay a dividend?

Zenith Drugs Ltd (ZENITHDRUG) shows a reported dividend yield of 1.18%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Zenith Drugs Ltd in?

Zenith Drugs Ltd (ZENITHDRUG) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is ZENITHDRUG listed on?

ZENITHDRUG is listed on NS.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)